Serotonin-specific drugs for anxiety and depressive disorders

D. S. Charney; J. H. Krystal; P. L. Delgado; G. R. Heninger

doi:10.1146/annurev.me.41.020190.002253

Serotonin-specific drugs for anxiety and depressive disorders

D. S. Charney, J. H. Krystal, P. L. Delgado, G. R. Heninger

Joe R & Teresa Lozano School of Medicine

Research output: Contribution to journal › Article › peer-review

67 Scopus citations

Abstract

In the last few years there has been a marked increase in knowledge regarding the possible roles of serotonin neuronal dysfunction in the pathophysiology and treatment of anxiety and depressive disorders. During the same time period, new drugs with specific actions on serotonin function have become available for clinical testing. This review provides an update on the efficacy of serotonin-specific drugs for anxiety and depressive disorders.

Original language	English (US)
Pages (from-to)	437-446
Number of pages	10
Journal	Annual review of medicine
Volume	41
Issue number	1
DOIs	https://doi.org/10.1146/annurev.me.41.020190.002253
State	Published - 1990

Keywords

Depression
Drugs
Serotonin receptors

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1146/annurev.me.41.020190.002253

Fingerprint Dive into the research topics of 'Serotonin-specific drugs for anxiety and depressive disorders'. Together they form a unique fingerprint.

Cite this

@article{9fb180c1039d417285547362e2fecf8c,

title = "Serotonin-specific drugs for anxiety and depressive disorders",

abstract = "In the last few years there has been a marked increase in knowledge regarding the possible roles of serotonin neuronal dysfunction in the pathophysiology and treatment of anxiety and depressive disorders. During the same time period, new drugs with specific actions on serotonin function have become available for clinical testing. This review provides an update on the efficacy of serotonin-specific drugs for anxiety and depressive disorders.",

keywords = "Depression, Drugs, Serotonin receptors",

author = "Charney, {D. S.} and Krystal, {J. H.} and Delgado, {P. L.} and Heninger, {G. R.}",

year = "1990",

doi = "10.1146/annurev.me.41.020190.002253",

language = "English (US)",

volume = "41",

pages = "437--446",

journal = "Annual Review of Medicine",

issn = "0066-4219",

publisher = "Annual Reviews Inc.",

number = "1",

}

TY - JOUR

T1 - Serotonin-specific drugs for anxiety and depressive disorders

AU - Charney, D. S.

AU - Krystal, J. H.

AU - Delgado, P. L.

AU - Heninger, G. R.

PY - 1990

Y1 - 1990

N2 - In the last few years there has been a marked increase in knowledge regarding the possible roles of serotonin neuronal dysfunction in the pathophysiology and treatment of anxiety and depressive disorders. During the same time period, new drugs with specific actions on serotonin function have become available for clinical testing. This review provides an update on the efficacy of serotonin-specific drugs for anxiety and depressive disorders.

AB - In the last few years there has been a marked increase in knowledge regarding the possible roles of serotonin neuronal dysfunction in the pathophysiology and treatment of anxiety and depressive disorders. During the same time period, new drugs with specific actions on serotonin function have become available for clinical testing. This review provides an update on the efficacy of serotonin-specific drugs for anxiety and depressive disorders.

KW - Depression

KW - Drugs

KW - Serotonin receptors

UR - http://www.scopus.com/inward/record.url?scp=0025273846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025273846&partnerID=8YFLogxK

U2 - 10.1146/annurev.me.41.020190.002253

DO - 10.1146/annurev.me.41.020190.002253

M3 - Article

C2 - 2139556

AN - SCOPUS:0025273846

VL - 41

SP - 437

EP - 446

JO - Annual Review of Medicine

JF - Annual Review of Medicine

SN - 0066-4219

IS - 1

ER -